| An integrated hypothesis for the serotonergic axonal loss induced by 3, 4-methylenedioxymethamphetamine. JE Sprague, SL Everman, DE Nichols Neurotoxicology 19 (3), 427-441, 1998 | 269 | 1998 |
| Uncoupling the agony from ecstasy EM Mills, ML Banks, JE Sprague, T Finkel Nature 426 (6965), 403-404, 2003 | 188 | 2003 |
| The monoamine oxidase-B inhibitor L-deprenyl protects against 3, 4-methylenedioxymethamphetamine-induced lipid peroxidation and long-term serotonergic deficits. JE Sprague, DE Nichols Journal of Pharmacology and Experimental Therapeutics 273 (2), 667-673, 1995 | 169 | 1995 |
| Hypothalamic-pituitary-thyroid axis and sympathetic nervous system involvement in hyperthermia induced by 3, 4-methylenedioxymethamphetamine (Ecstasy) JE Sprague, ML Banks, VJ Cook, EM Mills Journal of Pharmacology and Experimental Therapeutics 305 (1), 159-166, 2003 | 152 | 2003 |
| Synthetic cathinones (“bath salts”) ML Banks, TJ Worst, DE Rusyniak, JE Sprague The Journal of emergency medicine 46 (5), 632-642, 2014 | 134 | 2014 |
| The role of the sympathetic nervous system and uncoupling proteins in the thermogenesis induced by 3, 4-methylenedioxymethamphetamine EM Mills, DE Rusyniak, JE Sprague Journal of molecular medicine 82, 787-799, 2004 | 112 | 2004 |
| Reinforcing effects of certain serotonin-releasing amphetamine derivatives D Marona-Lewicka, GS Rhee, JE Sprague, DE Nichols Pharmacology Biochemistry and Behavior 53 (1), 99-105, 1996 | 110 | 1996 |
| Toxin-induced hyperthermic syndromes DE Rusyniak, JE Sprague Medical Clinics 89 (6), 1277-1296, 2005 | 105 | 2005 |
| Hippocampal serotonergic damage induced by MDMA (ecstasy): effects on spatial learning JE Sprague, AS Preston, M Leifheit, B Woodside Physiology & behavior 79 (2), 281-287, 2003 | 103 | 2003 |
| Community pharmacists ‘attitudes towards clinical utility and ethical implications of pharmacogenetic testing S Tuteja, K Haynes, C Zayac, JE Sprague, B Bernhardt, R Pyeritz Personalized medicine 10 (8), 793-800, 2013 | 93 | 2013 |
| Carvedilol reverses hyperthermia and attenuates rhabdomyolysis induced by 3, 4-methylenedioxymethamphetamine (MDMA, Ecstasy) in an animal model JE Sprague, P Moze, D Caden, DE Rusyniak, C Holmes, DS Goldstein, ... Critical care medicine 33 (6), 1311-1316, 2005 | 89 | 2005 |
| Roles of norepinephrine, free fatty acids, thyroid status, and skeletal muscle uncoupling protein 3 expression in sympathomimetic-induced thermogenesis JE Sprague, X Yang, J Sommers, TL Gilman, EM Mills Journal of Pharmacology and Experimental Therapeutics 320 (1), 274-280, 2007 | 88 | 2007 |
| The pharmacology and toxicology of the ‘Holy Trinity’ JT Horsfall, JE Sprague Basic & clinical pharmacology & toxicology 120 (2), 115-119, 2017 | 80 | 2017 |
| Attenuation of 3,4‐methylenedioxymethamphetamine (MDMA, Ecstasy)‐induced rhabdomyolysis with α1‐ plus β3‐adrenoreceptor antagonists JE Sprague, RE Brutcher, EM Mills, D Caden, DE Rusyniak British journal of pharmacology 142 (4), 667-670, 2004 | 67 | 2004 |
| In vivo microdialysis and conditioned place preference studies in rats are consistent with abuse potential of tramadol JE Sprague, M Leifheit, J Selken, MM Milks, DH Kinder, DE Nichols Synapse 43 (2), 118-121, 2002 | 64 | 2002 |
| The complementary and divergent roles of uncoupling proteins 1 and 3 in thermoregulation CL Riley, C Dao, MA Kenaston, L Muto, S Kohno, SM Nowinski, ... The Journal of physiology 594 (24), 7455-7464, 2016 | 62 | 2016 |
| Psychostimulant-like effects of p-fluoroamphetamine in the rat D Marona-Lewicka, GS Rhee, JE Sprague, DE Nichols European journal of pharmacology 287 (2), 105-113, 1995 | 60 | 1995 |
| UCP3 and thyroid hormone involvement in methamphetamine-induced hyperthermia JE Sprague, NM Mallett, DE Rusyniak, E Mills Biochemical pharmacology 68 (7), 1339-1343, 2004 | 53 | 2004 |
| The role of mitochondrial uncoupling in 3, 4-methylenedioxymethamphetamine-mediated skeletal muscle hyperthermia and rhabdomyolysis DE Rusyniak, SL Tandy, SK Hekmatyar, E Mills, DJ Smith, N Bansal, ... Journal of Pharmacology and Experimental Therapeutics 313 (2), 629-639, 2005 | 50 | 2005 |
| Inhibition of MAO-B protects against MDMA-induced neurotoxicity in the striatum JE Sprague, DE Nichols Psychopharmacology 118, 357-359, 1995 | 49 | 1995 |
